Intracellular drug delivery by genetically engineered high-density lipoprotein nanoparticles

Author： Murakami Tatsuya   Wijagkanalan Wassana   Hashida Mitsuru   Tsuchida Kunihiro  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.5, Iss.6, 2010-08, pp. : 867-879

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-density lipoprotein and innate immunity

By Jensby Nielsen Marianne   Bo Nielsen Lars   Moestrup Søøren K  

Future Lipidology, Vol. 1, Iss. 6, 2006-12 ,pp. : 729-734

Future Medicine

Access to resources Recommend Favorite

Significance of High‐Density Lipoprotein Cholesterol*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 26, Iss. 10, 1978-10 ,pp. : 440-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-density lipoprotein: A fall from grace?

By van Leuven Sander   Stroes Erik   Kastelein John  

Annals of Medicine, Vol. 40, Iss. 8, 2008-12 ,pp. : 584-593

Informa Healthcare

Access to resources Recommend Favorite

Effects of high-density lipoprotein on endothelium-dependent vasorelaxation

By McAllister Richard M.   Morris David M.   Weimer Cory M.   Laughlin M. H.  

Applied Physiology, Nutrition, and Metabolism, Vol. 35, Iss. 3, 2010-06 ,pp. : 319-327

NRC Research Press

Access to resources Recommend Favorite

New revelations of high-density lipoprotein activity

By  

Future Lipidology, Vol. 1, Iss. 6, 2006-12 ,pp. : 659-661

Future Medicine

Access to resources Recommend Favorite